NasdaqCM - Nasdaq Real Time Price USD
CNS Pharmaceuticals, Inc. (CNSP)
1.1575
-0.2025
(-14.92%)
As of 3:47:17 PM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-17,113.2990
-17,113.2990
-14,140.0310
-10,557.8150
-13,538.3090
Investing Cash Flow
-4.1880
-4.1880
-3.9010
-4.4220
-5.7480
Financing Cash Flow
23,030.1440
23,030.1440
4,637.2460
15,613.1270
4,509.0810
End Cash Position
6,461.3780
6,461.3780
548.7210
10,055.4070
5,004.5170
Income Tax Paid Supplemental Data
0
0
0
0
0
Interest Paid Supplemental Data
13.5990
13.5990
13.8050
8.0940
9.7740
Capital Expenditure
-4.1880
-4.1880
-3.9010
-4.4220
-5.7480
Issuance of Capital Stock
23,376.3750
23,376.3750
2,317.5990
16,038.0930
4,653.8210
Repayment of Debt
-300.8060
-300.8060
-438.7330
-427.7000
-477.4900
Free Cash Flow
-17,117.4870
-17,117.4870
-14,143.9320
-10,562.2370
-13,544.0570
12/31/2021 - 11/8/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
HCWB HCW Biologics Inc.
9.08
-9.70%
XLO Xilio Therapeutics, Inc.
0.8901
-22.60%
TOVX Theriva Biologics, Inc.
0.5657
+1.02%
CTMX CytomX Therapeutics, Inc.
2.3450
-6.20%
HEPA Hepion Pharmaceuticals, Inc.
0.3180
0.00%
KTTA Pasithea Therapeutics Corp.
0.9356
+8.79%
PLRZ Polyrizon Ltd.
0.0124
-56.49%
ZVSA ZyVersa Therapeutics, Inc.
0.5000
-3.46%
ALZN Alzamend Neuro, Inc.
3.8400
-8.13%
CRVS Corvus Pharmaceuticals, Inc.
3.6000
-7.46%